Celldex Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 0.07, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Celldex Therapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 5214 days, from 255 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Celldex Therapeutics inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Celldex Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CLDX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	7155.56 %	-78.38 %	187.86 %	-89.44 %	-94.13 %
Y / Y Revenue Change	-96.99 %	-97.84 %	-89.79 %	-	-70.78 %
Receivable Turnover Ratio (TTM)	0.07	1.43	1.9	5.35	8.56
CLDX's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	5152	256	192	68	43
Seq. Receivable Change	2739.13 %	-88.59 %	2138.89 %	0 %	-91.54 %
Seq. Revenue Change	46.67 %	-87.5 %	-	-	5.04 %

Receivable Turnover Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

CLDX Company Profile • Back to CLDX Efficiency Comparisons • Compare CLDX Receivables Turnover Ratio to its Competitors

Financial Statements
Celldex Therapeutics Inc 's Accounts Receivable	$ 7 Millions	Visit CLDX's Balance sheet
Celldex Therapeutics Inc 's Sales TTM	$ 0 Millions	Visit CLDX's Income Statement
Sources of CLDX's Revenues		Visit CLDX's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CLDX's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CLDX's Growth Rates	CLDX's Roa	CLDX's Inventory Turnover Ratio	CLDX's Dividend Comparisons
CLDX's Profitability Ratios	CLDX's Roi	CLDX's Asset Turnover Ratio	CLDX's Dividend Growth
CLDX's Valuation Ratios	CLDX's Roe	CLDX's Financial Strength Ratios	CLDX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Jun 30 2026

Receivable at quarter ending Jun 30 2026

Date modified: 2026-09-08T15:11:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.